Arecor Therapeutics PLC (AIM:AREC) said it has signed a formulation agreement with Intas Pharmaceuticals, where it plans to create “superior reformulations” of existing Intas products. It will also use its know-how to improve drugs in development.
Gaming Realms PLC (AIM:GMR, FRA:RNE1, OTCQX:PSDMF) told investors its first Slingo game has now gone live in Pennsylvania, following the company’s recent award of an interactive gaming manufacturer licence in the state.
Avation PLC (LSE:AVAP), a commercial passenger aircraft leasing company, said it repaid the outstanding export credit agency (ECA) insured loans associated with eight ATR 72 aircraft that were previously on lease to Virgin Australia (ASX:VAH) Airlines.
Panther Metals PLC (LSE:PALM) appointed Sanlam Private Wealth Pty Ltd and Kerr Allan as joint lead managers for the proposed listing of the company’s subsidiary Panther Metals Ltd on the Australian Securities Exchange. Panther Metals Ltd has also raised A$300,000 Australian dollars to fund the listing process.
Power Metal Resources PLC (AIM:POW, FRA:2M5) is selling its Schreiber-Hemlo project interests in Ontario, Canada to First Class Metals Ltd. The consideration is GBP1mln, payable through the issue of 333,334 new ordinary shares at 300p each.
Chariot Ltd (AIM:CHAR, OTC:OIGLF, FRA:C62) has signed a contract with Stena Drilling, one of the world’s foremost independent drilling contractors, to use its Stena Don drilling rig for the planned Anchois gas appraisal well within the Lixus licence, offshore Morocco.
Induction Healthcare Group PLC (AIM:INHC) made James Balmain its sole chief executive and appointed former joint-CEO Hugo Stephenson as group executive director, with a focus on group product strategy and business development, particularly in the Asia Pacific region.
Blackbird PLC (AIM:BIRD, OTCQX:BBRDF) said a global broadcast company has licensed its core video technology for a five-year period. It is the first Original Equipment Manufacturer (OEM) licensing deal for Blackbird and is worth at least an estimated EUR2mln (around GBP1.7mln) over the contract length.
European Metals Holdings Ltd said a new operations manager has been appointed for its world-class Cinovec lithium/tin project in the Czech Republic.
Poolbeg Pharma PLC (AIM:POLB) said its US patent assessment work is going to plan. In an update, it told investors the official reviewing its application to protect its main asset, POLB 001, has indicated that the majority of the claims, including the main claim, would be “allowable”.
AFC Energy PLC (AIM:AFC, OTC:AFGYF, FRA:QC8) said its remuneration committee is putting in place a new long term performance shares plan for executive directors and senior management. It will initially be applied to the board level executives and then in turn to other senior management in March 2022.
Tiziana Life Sciences PLC (NASDAQ:TLSA, LSE:TILS, FRA:RTRA, OTC:TIZAF) will host a conference call and audio webcast on Wednesday, September 8, at 9.15pm BST (4:15pm ET) to discuss its recently announced exclusive license agreement to evaluate Foralumab, the company’s novel, fully human anti-CD3 monoclonal antibody, in conjunction with allogenic CAR T candidates for cancer treatment.
Allergy Therapeutics PLC (AIM:AGY, FRA:HHU) will host a webinar entitled ‘VLP Peanut; a next generation peanut allergy immunotherapy’, on Friday 17 September 2021 at 2pm BST (9am ET), with an introduction from chief executive officer Manuel Llobet and a presentation by key opinion leader Dr Mo Shamji, reader in immunology & allergy at Imperial College London.
Faron Pharmaceuticals Ltd announced that Dr Juho Jalkanen, chief development officer, will present at the virtual HC Wainwright Global Investor Conference, with the presentation available on-demand from Monday, September 13 at 12pm BST (7am ET), 2pm EEST). The presentation will be available in the “Investors” section on Faron’s website.
Medica Group PLC (LSE:MGP, FRA:2MI) held a capital markets day for institutional investors and analysts today, with a summary of the presentation made available following the end of the meeting at www.medicagroupplc.com/investors.